These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 11718092
21. [Membranous nephropathy following allogeneic peripheral blood stem cell transplantation in a boy with anaplastic large cell lymphoma]. Park YD, Hamada M, Higuchi B, Kishimoto T, Inagaki J, Nishiguchi M, Shimoyama H, Nakajima M, Nakagawa A, Yoshioka A. Rinsho Ketsueki; 2004 Nov; 45(11):1193-7. PubMed ID: 15609686 [Abstract] [Full Text] [Related]
22. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH, Zhang C, Zhang X, Gao L, Gao L, Kong PY, Peng XG, Qi DG, Sun AH, Zeng DF, Liu H, Gong Y, Wang QY. Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [Abstract] [Full Text] [Related]
23. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients. Shaiegan M, Iravani M, Babaee GR, Ghavamzadeh A. Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290 [Abstract] [Full Text] [Related]
24. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation: etiology and pathogenesis. Luo XD, Liu QF, Zhang Y, Sun J, Wang GB, Fan ZP, Yi ZS, Ling YW, Wei YQ, Liu XL, Xu B. Blood Cells Mol Dis; 2011 Feb 15; 46(2):182-7. PubMed ID: 21212006 [Abstract] [Full Text] [Related]
25. Ocular findings after allogeneic hematopoietic stem cell transplantation. Tabbara KF, Al-Ghamdi A, Al-Mohareb F, Ayas M, Chaudhri N, Al-Sharif F, Al-Zahrani H, Mohammed SY, Nassar A, Aljurf M. Ophthalmology; 2009 Sep 15; 116(9):1624-9. PubMed ID: 19729097 [Abstract] [Full Text] [Related]
26. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors]. Huang XJ, Xu LP, Ren HY, Zhang YC, Guo NL, Lu DP. Zhonghua Yi Xue Za Zhi; 2003 May 10; 83(9):766-9. PubMed ID: 12899755 [Abstract] [Full Text] [Related]
27. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients. Lo JW, Leung AY, Huang XR, Lie AK, Metz C, Bucala R, Liang R, Lan HY. Bone Marrow Transplant; 2002 Sep 10; 30(6):375-80. PubMed ID: 12235522 [Abstract] [Full Text] [Related]
28. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy. Talmadge JE. Int Immunopharmacol; 2003 Aug 10; 3(8):1121-43. PubMed ID: 12860168 [Abstract] [Full Text] [Related]
29. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma. Zhang XH, Huang XJ, Liu KY, Xu LP, Liu DH, Chen H, Chen YH, Wang JZ, Han W, Lu DP. Chin Med J (Engl); 2007 Mar 20; 120(6):463-8. PubMed ID: 17439737 [Abstract] [Full Text] [Related]
30. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation. Dander E, Balduzzi A, Zappa G, Lucchini G, Perseghin P, Andrè V, Todisco E, Rahal D, Migliavacca M, Longoni D, Solinas G, Villa A, Berti E, Mina PD, Parma M, Allavena P, Biagi E, Rovelli A, Biondi A, D'Amico G. Transplantation; 2009 Dec 15; 88(11):1261-72. PubMed ID: 19996925 [Abstract] [Full Text] [Related]
31. De novo postallogeneic hematopoietic stem cell transplant membranous nephropathy. Numata A, Morishita Y, Mori M, Saito O, Takemoto F, Ando Y, Muto S, Yumura W, Kusano E. Exp Clin Transplant; 2013 Feb 15; 11(1):75-8. PubMed ID: 22809119 [Abstract] [Full Text] [Related]
32. Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation. Abboud I, Porcher R, Robin M, de Latour RP, Glotz D, Socié G, Peraldi MN. Biol Blood Marrow Transplant; 2009 Oct 15; 15(10):1251-7. PubMed ID: 19747632 [Abstract] [Full Text] [Related]
33. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation]. Lin Q, Dong M, Wang QM, Wen JY, Wu XY. Ai Zheng; 2006 Oct 15; 25(10):1261-5. PubMed ID: 17059772 [Abstract] [Full Text] [Related]
34. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease. Bridge AT, Nelson RP, Schwartz JE, Mirowski GW, Billings SD. Am J Dermatopathol; 2007 Feb 15; 29(1):1-6. PubMed ID: 17284954 [Abstract] [Full Text] [Related]
35. Membranous nephropathy is developed under Th2 environment in chronic graft-versus-host disease. Nakashima H. Med Hypotheses; 2007 Feb 15; 69(4):787-91. PubMed ID: 17398013 [Abstract] [Full Text] [Related]